The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Abstract
BACKGROUND: Insulin-like growth factors (IGFs), in particular IGF-I and IGF-II, strongly stimulate the proliferation of a variety of cancer cells, including those from lung cancer. To examine the possible causal role of IGFs in lung cancer development, we compared plasma levels of IGF-I, IGF-II, and an IGF-binding protein (IGFBP-3) in patients with newly diagnosed lung cancer and in control subjects. METHODS: From an ongoing hospital-based, case-control study, we selected 204 consecutive patients with histologically confirmed, primary lung cancer and 218 control subjects who were matched to the case patients by age, sex, race, and smoking status. IGF-I, IGF-II, and IGFBP-3 plasma levels were measured by enzyme-linked immunosorbent assay and then divided into quartiles, based on their distribution in the control subjects. Associations between the IGF variables and lung cancer risk were estimated by use of odds ratios (ORs). Reported P values are two-sided. RESULTS: IGF and IGFBP-3 levels were positively correlated (all r>.27; all P<.001). High plasma levels of IGF-I were associated with an increased risk of lung cancer (OR = 2.06; 95% confidence interval [CI] = 1.19-3.56; P = .01), and this association was dose dependent in both univariate and multivariate analyses. Plasma IGFBP-3 showed no association with lung cancer risk unless adjusted for IGF-I level; when both of these variables were analyzed together, high plasma levels of IGFBP-3 were associated with reduced risk of lung cancer (OR = 0.48; 95% CI = 0.25-0.92; P = .03). IGF-II was not associated with lung cancer risk. CONCLUSIONS: Plasma levels of IGF-I are higher and plasma levels of IGFBP-3 are lower in patients with lung cancer than in control subjects. If these findings can be confirmed in prospective studies, measuring levels of IGF-I and IGFBP-3 in blood may prove useful in assessing lung cancer risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor
LEROITH, D., WERNER, H., BEITNER-JOHNSON, D., & ROBERTS, A. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,423
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Juul, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.744 · Cited by 776
Insulin-like growth factors and cancer
Macaulay, V. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.65 · Cited by 601
The insulin-like growth factor I receptor: a key to tumor growth?
Baserga, R. (1995) · PubMed · Cited by 552
Cohen, P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1046 · Cited by 497
De Mellow, J. S. M., & Baxter, R. C. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80824-6 · Cited by 483
Dunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G. S., Wilson, R., & Barrett, J. C. (1997) · PubMed · Cited by 438
Werner, H., Karnieli, E., Rauscher, F. J., & LeRoith, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8318 · Cited by 370
Gucev, Z. S., Oh, Y., Kelley, K. M., & Rosenfeld, R. G. (1996) · PubMed · Cited by 253
Epidemiology of Insulin-like Growth Factor-I in Elderly Men and Women: The Rancho Bernardo Study
Goodman-Gruen, D., & Barrett-Connor, E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009065 · Cited by 238
Parrizas, M. (1997) · Endocrinology · doi:10.1210/en.138.3.1355 · Cited by 219
Dunn, S. E., Hardman, R. A., Kari, F. W., & Barrett, J. C. (1997) · PubMed · Cited by 204
Angelloz-Nicoud, P. (1995) · Endocrinology · doi:10.1210/en.136.12.5485 · Cited by 167
Nuclear Localization of Insulin-Like Growth Factor Binding Protein 3 in a Lung Cancer Cell Line
Jaques, G., Noll, K., Wegmann, B., Witten, S., Kogan, E., Radulescu, R. T., & HAVEMANN, K. (1997) · Endocrinology · doi:10.1210/endo.138.4.5177 · Cited by 153
Chen, J., Shao, Z., Sheikh, M. S., Hussain, A., LeRoith, D., Roberts, C. T., & Fontana, J. A. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041580110 · Cited by 151
Conover, C. A., & León, D. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37248-4 · Cited by 123
Adamo, M. L., Shao, Z. M., Lanau, F., Chen, J. C., Clemmons, D. R., Roberts, C. T., LeRoith, D., & Fontana, J. A. (1992) · Endocrinology · doi:10.1210/en.131.4.1858 · Cited by 97
Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro
Furlanetto, R. W., Harwell, S. E., & Frick, K. K. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.4.8052269 · Cited by 89
Rechler, M. M. (1997) · Endocrinology · doi:10.1210/endo.138.7.5355 · Cited by 87
Favoni, R. E., de Cupis, A., Ravera, F., Cantoni, C., Pirani, P., Ardizzoni, A., Noonan, D. M., & Biassoni, R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560618 · Cited by 63
Takahashi, K., & Suzuki, K. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550322 · Cited by 62
Freed, K. A., & Herington, A. C. (1989) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0030183 · Cited by 38
Cited by
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Self-citationSystemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.10001 · Cited by 1,279
Metadata
- Authors
- Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01-20
- Volume
- 91
- Issue
- 2
- Pages
- 151-156
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2098547168
- Cited by
- 554
- References
- 29
- FWCI
- 17.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.